Icariside II Alleviates Chondrocyte Inflammatory Injury by Inhibiting the TNIP2/NF-κB Pathway
Cell Biochemistry and Biophysics · 2025
DOI: 10.1007/s12013-024-01635-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2025. Verfasst von Jiajun Mei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Medicine, Wuhan University of Science and Technology Affiliated Puren Hospital, Wuhan, China. Hauptthemen laut MEDLINE: Chondrocytes, Signal Transduction, NF-kappa B, Flavonoids. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Health and Health Research Project of the Metallurgical Safety and Health Branch of the Chinese Society of Metals.
Abstract (Originalsprache)
Icariside II exerts protective effects against various diseases; however, its specific effects on osteoarthritis (OA) remain unclear. Therefore, in this study, we aimed to investigate the effects of icariside II in an in vitro model of OA and analyze its action mechanisms. We established an in vitro OA model by treating a human chondrocyte cell line (CHON-001) with interleukin (IL)-1β, followed by treatment with different concentrations of icariside II. Cell viability was measured using the methyl thiazolyl tetrazolium assay, and the level of lactate dehydrogenase (LDH) released from cells was determined using the appropriate kit. Tumor necrosis factor (TNF)-α, IL-6, and IL-8 levels were determined via enzyme-linked immunosorbent assay. Flow cytometry was used to assess apoptosis. Apoptosisrelated protein expression levels and TNFAIP3-interacting protein 2 (TNIP2)/nuclear factor (NF)-κB signaling pathway were analyzed via reverse transcription-quantitative polymerase chain reaction and western blotting. Furthermore, TNIP2-small interfering RNA (siRNA) was used to determine whether the TNIP2/NF-κB pathway influences the effects of icariside II on OA. Results indicated that Icariside II did not exert any significant toxic effects on CHON-001 cells. It inhibited IL-1β-induced apoptosis and increase in LDH levels and enhanced the inflammatory response. Additionally, icariside II reversed the IL-1β-induced decrease in TNIP2 levels and increase in NF-κB phosphorylation. TNIP2-siRNA revealed that the TNIP2/NF-κB signaling pathway influenced the alleviating effects of icariside II on OA. In conclusion, our results revealed that icariside II attenuated IL-1β-induced inflammatory injury in chondrocytes by increasing TNIP2 expression and inhibiting NF-κB pathway activation, highlighting its therapeutic potential for OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pain Medicine, Wuhan University of Science and Technology Affiliated Puren Hospital, Wuhan, China.
- Department of Pain Medicine, Wuhan University of Science and Technology Affiliated Puren Hospital, Wuhan, China. Huangkai1021@wust.edu.cn.
Förderung
- Health and Health Research Project of the Metallurgical Safety and Health Branch of the Chinese Society of Metals
Zitieren
APA
Mei, J., Ke, H., & Zhu, J. (2025). Icariside II Alleviates Chondrocyte Inflammatory Injury by Inhibiting the TNIP2/NF-κB Pathway. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01635-9
Vancouver
Mei J, Ke H, Zhu J. Icariside II Alleviates Chondrocyte Inflammatory Injury by Inhibiting the TNIP2/NF-κB Pathway. Cell Biochemistry and Biophysics. 2025. doi:10.1007/s12013-024-01635-9
BibTeX
@article{Mei2025,
author = {Mei, Jiajun and Ke, Hongkui and Zhu, Junsong},
title = {Icariside II Alleviates Chondrocyte Inflammatory Injury by Inhibiting the TNIP2/NF-κB Pathway},
journal = {Cell Biochemistry and Biophysics},
year = {2025},
doi = {10.1007/s12013-024-01635-9}
}
EUVIMED